bortezomib, ifosfamide, and vinorelbine tartrate
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for bortezomib, ifosfamide, and vinorelbine tartrate, covering 2014-04-10 to 2014-04-10. Get the full timeline:
Most recent: Clinical Trial Update: Bortezomib, Ifosfamide, and Vinorelbine Tartrate in Treating Young Patients With Hodgkin's Lymphoma That is Recurrent or Did Not Respond to Previous Therapy [Phase 2]